This is a "connection" page, showing publications co-authored by Bo Lu and Tingting Zhan.
Connection Strength

  1. Du S, McCall N, Park K, Guan Q, Fontina P, Ertel A, Zhan T, Dicker AP, Lu B. Blockade of Tumor-Expressed PD-1 promotes lung cancer growth. Oncoimmunology. 2018; 7(4):e1408747.
    View in: PubMed
    Score: 0.188
  2. Wang YA, Sun Y, Le Blanc JM, Solomides C, Zhan T, Lu B. Nitrilase 1 modulates lung tumor progression in vitro and in vivo. Oncotarget. 2016 Apr 19; 7(16):21381-92.
    View in: PubMed
    Score: 0.166
  3. Tao Z, Le Blanc JM, Wang C, Zhan T, Zhuang H, Wang P, Yuan Z, Lu B. Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo. Clin Cancer Res. 2016 Jan 1; 22(1):122-33.
    View in: PubMed
    Score: 0.163
  4. Song AJ, Evans N, Cowan S, Guo J, Zhan T, Lu B, Werner-Wasik M. Stereotactic body radiation therapy (SBRT) for patients with stage I non-small cell lung cancer is applicable to more tumors than sublobar resection. J Thorac Dis. 2021 Mar; 13(3):1576-1583.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.